COVID-19 is an ongoing pandemic with many challenges that are now extending to 
its intriguing long-term sequel. 'Long-COVID-19' is a term given to the 
lingering or protracted illness that patients of COVID-19 continue to experience 
even in their post-recovery phase. It is also being called 'post-acute 
COVID-19', 'ongoing symptomatic COVID-19', 'chronic COVID-19', 'post COVID-19 
syndrome', and 'long-haul COVID-19'. Fatigue, dyspnea, cough, headache, brain 
fog, anosmia, and dysgeusia are common symptoms seen in Long-COVID-19, but more 
varied and debilitating injuries involving pulmonary, cardiovascular, cutaneous, 
musculoskeletal and neuropsychiatric systems are also being reported. With the 
data on Long-COVID-19 still emerging, the present review aims to highlight its 
epidemiology, protean clinical manifestations, risk predictors, and management 
strategies. With the re-emergence of new waves of SARS-CoV-2 infection, 
Long-COVID-19 is expected to produce another public health crisis on the heels 
of current pandemic. Thus, it becomes imperative to emphasize this condition and 
disseminate its awareness to medical professionals, patients, the public, and 
policymakers alike to prepare and augment health care facilities for continued 
surveillance of these patients. Further research comprising cataloging of 
symptoms, longer-ranging observational studies, and clinical trials are 
necessary to evaluate long-term consequences of COVID-19, and it warrants 
setting-up of dedicated, post-COVID care, multi-disciplinary clinics, and 
rehabilitation centers.